226 related articles for article (PubMed ID: 35533645)
1. Recent Advances in Immune-Based Therapies for Type 1 Diabetes.
Smigoc Schweiger D
Horm Res Paediatr; 2023; 96(6):631-645. PubMed ID: 35533645
[TBL] [Abstract][Full Text] [Related]
2. Diabetes type 1: Can it be treated as an autoimmune disorder?
Vallianou NG; Stratigou T; Geladari E; Tessier CM; Mantzoros CS; Dalamaga M
Rev Endocr Metab Disord; 2021 Dec; 22(4):859-876. PubMed ID: 33730229
[TBL] [Abstract][Full Text] [Related]
3. Preventing type 1 diabetes development and preserving beta-cell function.
Mastrandrea LD; Quattrin T
Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):386-391. PubMed ID: 35799459
[TBL] [Abstract][Full Text] [Related]
4. Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.
Simmons KM; Gottlieb PA; Michels AW
Curr Diab Rep; 2016 Oct; 16(10):97. PubMed ID: 27558810
[TBL] [Abstract][Full Text] [Related]
5. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
6. Immune interventions to preserve β cell function in type 1 diabetes.
Ehlers MR
J Investig Med; 2016 Jan; 64(1):7-13. PubMed ID: 26225763
[TBL] [Abstract][Full Text] [Related]
7. Lessons and gaps in the prediction and prevention of type 1 diabetes.
Mameli C; Triolo TM; Chiarelli F; Rewers M; Zuccotti G; Simmons KM
Pharmacol Res; 2023 Jul; 193():106792. PubMed ID: 37201589
[TBL] [Abstract][Full Text] [Related]
8. Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function.
Fanaropoulou NM; Tsatsani GC; Koufakis T; Kotsa K
Expert Rev Clin Immunol; 2024 Feb; 20(2):185-196. PubMed ID: 37937833
[TBL] [Abstract][Full Text] [Related]
9. New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P; Leslie RD
Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
[TBL] [Abstract][Full Text] [Related]
10. Clinical and experimental treatment of type 1 diabetes.
Long SA; Buckner JH
Clin Exp Immunol; 2022 Dec; 210(2):105-113. PubMed ID: 35980300
[TBL] [Abstract][Full Text] [Related]
11. Targeted immune interventions for type 1 diabetes: not as easy as it looks!
Rigby MR; Ehlers MR
Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):271-8. PubMed ID: 24983393
[TBL] [Abstract][Full Text] [Related]
12. Recent trends and advances in type 1 diabetes therapeutics: A comprehensive review.
Singh A; Afshan N; Singh A; Singh SK; Yadav S; Kumar M; Sarma DK; Verma V
Eur J Cell Biol; 2023 Jun; 102(2):151329. PubMed ID: 37295265
[TBL] [Abstract][Full Text] [Related]
13. Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside.
Brawerman G; Thompson PJ
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339173
[TBL] [Abstract][Full Text] [Related]
14. Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes.
Kroger CJ; Clark M; Ke Q; Tisch RM
Front Immunol; 2018; 9():1891. PubMed ID: 30166987
[TBL] [Abstract][Full Text] [Related]
15. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.
Jacobsen LM; Newby BN; Perry DJ; Posgai AL; Haller MJ; Brusko TM
Curr Diab Rep; 2018 Aug; 18(10):90. PubMed ID: 30168021
[TBL] [Abstract][Full Text] [Related]
16. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
17. Combination Immunotherapy for Type 1 Diabetes.
Bone RN; Evans-Molina C
Curr Diab Rep; 2017 Jul; 17(7):50. PubMed ID: 28534310
[TBL] [Abstract][Full Text] [Related]
18. Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes.
Infante M; Ricordi C; Sanchez J; Clare-Salzler MJ; Padilla N; Fuenmayor V; Chavez C; Alvarez A; Baidal D; Alejandro R; Caprio M; Fabbri A
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31514368
[TBL] [Abstract][Full Text] [Related]
19. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
20. The immunology of type 1 diabetes.
Herold KC; Delong T; Perdigoto AL; Biru N; Brusko TM; Walker LSK
Nat Rev Immunol; 2024 Jun; 24(6):435-451. PubMed ID: 38308004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
